UroGen Pharma URGN
NASDAQ URGN
$41.40 +0.85 (+2.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Cash from Financing Activities (2017 - 2026)

Updated

UroGen Pharma (URGN) recorded Cash from Financing Activities of $500,000 in Q2 2026, up 68.9% from $296,000 a year earlier but down 99.2% from the prior quarter.

Analysis

UroGen Pharma (URGN) Cash from Financing Activities (2017 - 2026) Analysis & Trends

On a TTM basis, UroGen Pharma's Cash from Financing Activities came in at $105.29 million as of Jun 30, 2026, up 163.2% year-over-year; for FY2025, it was $39.92 million, down 79.5% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $194.62 million in FY2024 (+66.4%), $116.93 million in FY2023 (+20.4%), $97.13 million in FY2022 (+34.3%) and $72.32 million in FY2021 (+337.6%).
  • Quarterly Cash from Financing Activities has ranged from -$168,000 in Q3 2021 to $116.08 million in Q3 2023 over the past five years.
  • On a year-over-year basis, Cash from Financing Activities rose in two of the last six quarters, with an average decline of 33.0%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 77.5% in Q4 2024, against a decline of 99.9% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $65.2 million (Q1 2026), $31.32 million (Q4 2025) and $8.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -8.78 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -5.05 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -47.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 2.34 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -3.66 Bn
10 UroGen Pharma 1.98 Bn 1.49 Bn 65.88 Mn 500,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Mar 31, 2026 65.20 Mn
Dec 31, 2025 31.32 Mn
Sep 30, 2025 8.27 Mn
Jun 30, 2025 296,000.00
Mar 31, 2025 34,000.00
Dec 31, 2024 71,000.00
Sep 30, 2024 39.61 Mn
Jun 30, 2024 100.29 Mn
Mar 31, 2024 54.66 Mn
Dec 31, 2023 40,000.00
Sep 30, 2023 116.08 Mn
Jun 30, 2023 143,000.00
Mar 31, 2023 671,000.00
Dec 31, 2022 25.37 Mn
Sep 30, 2022 1.10 Mn
Jun 30, 2022 -77,000.00
Mar 31, 2022 70.74 Mn
Dec 31, 2021 -32,000.00
Sep 30, 2021 -168,000.00
API Access

UroGen Pharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=URGN&period=max&api_key=YOUR_API_KEY